abstract |
The present invention relates to compounds of formula I, wherein A, Z, R 1a , R 1b , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , R 10 , R a , R b and n is as defined herein, and the compound is an inhibitor of PAK1. The present application also discloses compositions and methods for treating cancer and hyperproliferative disorders. |